-
Company Profile
Trigon Metals Inc – Company Profile
Trigon Metals Inc (TMI) is a metals and mining company that carries out mineral exploration and development. TMI also carries out the acquisition, and maintenance of mines and mineral properties in the African country of Namibia. The company's product is copper. TMI projects include Kombat Mine and Silver Hill Project. It also carries out establishing ore reserves, developing metallurgical processes and also involved in acquiring construction and operating permits to construct mining and other processing facilities. The company operates in...
Add to Basket -
Product Insights
Quarterly Nuts & Seeds pricing trends in the United Arab Emirates
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Nuts & Seeds pricing trends in the United Arab Emirates" serves as a...
-
Company Insights
Ethias – Digital Transformation Strategies
Ethias Digital Transformation Strategies Report Overview Ethias is tapping into key disruptive technologies including AI/machine learning (ML), big data, cloud, data analytics, insurtech, and data centers to digitally transform its operations. The annual ICT spending of Ethias was estimated at $ 139.8 million for 2022. A major share of this spending is earmarked for acquiring software, hardware, and ICT services from vendors. Ethias provides life and non-life insurance products to individuals, public sector entities, and corporate companies. Its non-life insurance...
-
Product Insights
Prince Rupert’s Trigon Pacific Terminal Expansion
Equip yourself with the essential tools needed to make informed and profitable decisions with our Prince Rupert’s Trigon Pacific Terminal Expansion report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? ·Unleash the full story: Dive deep into the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (lidocaine + oxybutynin) SR
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (lidocaine + oxybutynin) SR Drug Details TRG-100 is under development for the treatment of...
-
Product Insights
Muscarinic Acetylcholine Receptor M2 (CHRM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Muscarinic Acetylcholine Receptor M2 (CHRM2) is expressed in various regions of the brain including the cerebellum, cerebral cortex, hippocampus, medulla, striatum, thalamus, lungs, and prostate. An increase in M2 receptors has been associated with depression. The CHRM2 pipeline market research report provides comprehensive information on the CHRM2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its...
-
Product Insights
Muscarinic Acetylcholine Receptor M4 (CHRM4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Muscarinic Acetylcholine Receptor M4 (CHRM4) mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides, and modulation of potassium channels through the action of G proteins. The CHRM4 pipeline market research report provides comprehensive information on the CHRM4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research, and development history as well...